6th Circuit Affirms Dismissal Of Abilify False Claims, Kickback Qui Tam Case

(October 30, 2017, 4:43 PM EDT) -- CINCINNATI — In a 2-1 ruling, a panel of the Sixth Circuit U.S. Court of Appeals on Oct. 27 affirmed the dismissal of a false claims/kickback lawsuit about alleged off-label marketing of the antipsychotic drug Abilify (United States of America, ex rel. Joseph Ibanez, et al. v. Bristol-Myers Squibb Company, et al., No. 16-3154, 6th Cir., 2017 U.S. App. LEXIS 21328)....

Attached Documents

Related Sections